Strides Alathur's Chennai facility received a successful GMP inspection from USFDA.

Strides Alathur, a subsidiary of Strides Pharma Science, received an EIR from USFDA confirming successful GMP inspection at its Chennai facility. The April 1-5, 2024, inspection resulted in a "Voluntary Action Indicated" classification, benefiting their current and future product offerings in the US. The Alathur facility produces tablets and capsules, catering to the US and other regulated markets.

5 months ago
4 Articles